This program is supported by an independent education grant from Lilly. This online education program has been designed for healthcare professionals globally excluding the UK.

Join internationally recognized Alzheimer’s disease experts Brad Dickerson, MD & Tammie Benzinger, MD for this free, accredited online teaching session exploring the latest evidence in identifying, mitigating, and managing ARIA in Alzheimer's Disease.

Accreditation:

• 1 AMA PRA Category 1 Credit™

Session Highlights

This session uses real-world clinical vignettes to examine the newest evidence guiding ARIA detection, management, and coordinated response across multidisciplinary teams.

• Examine the latest evidence base guiding patient-centered ARIA risk discussions. Through an APOE4+ case, faculty compare approaches to integrating emerging ARIA risk data, patient preferences, and eligibility considerations within contemporary shared decision-making.
• Review subtle early ARIA presentations with updated radiologic and clinical insights. Explore real-world MRI examples and early symptom patterns, with faculty discussing current interpretation nuances and how evolving evidence informs decision thresholds.
• Explore current strategies for ARIA risk mitigation across diverse clinical scenarios. Using a prior ARIA-H case, faculty discuss evidence-informed approaches to dose adjustment, MRI surveillance timing, and APOE-based risk considerations as reflected in the newest guidance.
• Discuss multidisciplinary ARIA escalation pathways shaped by emerging data. Walk through a suspected ARIA event from ED presentation to radiology and neurology coordination, highlighting workflow variations, communication practices, and system-level considerations reflected in recent evidence.

Who Should Attend?

This program is designed for healthcare professionals involved in Alzheimer’s disease diagnosis, imaging, treatment, and acute evaluation, including:

• Neurologists
• Radiologists and Neuroradiologists
• Emergency Medicine Physicians
• Psychiatrists and Geriatric Psychiatrists
• Primary Care Physicians (MD/DO)
• Nurse Practitioners and Physician Assistants
• Infusion Center Staff
• Nursing Staff
• Triage Specialists
• Frontline Clinical Support Teams

Faculty

Brad Dickerson, MD, is Professor of Neurology at Harvard Medical School and directs both the Frontotemporal Disorders Unit and the Neuroimaging Core of the MGH Alzheimer’s Disease Research Center at Massachusetts General Hospital. A leading behavioral neurologist, he specializes in Alzheimer’s disease, primary progressive aphasia, and related neurodegenerative conditions, with expertise in advanced neuroimaging and diagnostic biomarkers. He has published extensively, leads a multidisciplinary research team, mentors trainees, and serves in national advisory roles for the Alzheimer’s Association and the Association for Frontotemporal Degeneration.

Tammie L. S. Benzinger, MD, PhD, is the Hugh Monroe Wilson Professor of Radiology and Chief of MRI Service at the Mallinckrodt Institute of Radiology at Washington University School of Medicine. Her work focuses on PET and MRI biomarkers for Alzheimer’s disease and related neurodegenerative disorders, and she directs imaging programs for the Knight Alzheimer’s Disease Research Center, DIAN, and DIAN-TU. A recognized leader in neuroradiology, she has received multiple national awards and is known for advancing early detection of degenerative brain disease through innovative imaging science.

Continuing Education Information

Commercial support: This activity received monetary support through an independent education grant from Lilly.

This continuing education activity will be provided by AffinityCE and MedAll. This activity will provide continuing education credit for physicians. A statement of participation is available to other attendees.

Disclosures

AffinityCE staff, MedAll staff, as well as planners and reviewers, have no relevant financial relationships with ineligible companies to disclose.

Mitigation of Relevant Financial Relationships

AffinityCE adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible companies. Relevant financial relationships were mitigated by the peer review of content by non-conflicted reviewers prior to the commencement of the program.

Activity Accreditation for Health Professions

Physicians

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and MedAll. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.

AffinityCE designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and MedAll. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.

AffinityCE designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™. Physician assistants should claim only the credit commensurate with the extent of their participation in the activity.

Nurse Practitioners

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and MedAll. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.

AffinityCE designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™. Nurse practitioners should claim only the credit commensurate with the extent of their participation in the activity.

Nurses & Other Professionals

All other health care professionals completing this continuing education activity will be issued a statement of participation indicating the number of hours of continuing education credit. This may be used for professional education CE credit. Please consult your accrediting organization or licensing board for their acceptance of this CE activity.

System Requirements

Mobile device (e.g., large-format smart phone; laptop or tablet computer) or desktop computer with a video display of at least 1024 × 768 pixels at 24-bit color depth, capable of connecting to the Internet at broadband or faster speeds, with a current version Internet browser and popular document viewing software (e.g., Microsoft Office, PDF viewer, image viewer) installed. Support for streaming or downloadable audio-visual materials (e.g., streaming MP4, MP3 audio) in hardware and software may be required to view, review, or participate in portions of the program.

Unapproved and/or off-label use disclosure

AffinityCE/MedAll requires CE faculty to disclose to the participants:

• When products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not US Food and Drug Administration [FDA] approved); and
• Any limitations on the information presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion.

Participation Costs

There is no cost to participate in this program.

Requirements for Completion

In order to receive credit for this activity, participants must review the content and complete the post-test and evaluation form. Statements of credit are awarded upon successful completion of the post-test and evaluation form.

Launch and Expiration Date: 20 January 2026 - 20 January 2026

Estimated time to complete this activity: 60 minutes

System Requirements

Mobile device (e.g., large-format smart phone; laptop or tablet computer) or desktop computer with a video display of at least 1024 × 768 pixels at 24-bit color depth, capable of connecting to the Internet at broadband or faster speeds, with a current version Internet browser and popular document viewing software (e.g., Microsoft Office, PDF viewer, image viewer) installed. Support for streaming or downloadable audio-visual materials (e.g., streaming MP4, MP3 audio) in hardware and software may be required to view, review, or participate in portions of the program.

Unapproved and/or off-label use disclosure

AffinityCE/MedAll requires CE faculty to disclose to the participants:

1. When products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not US Food and Drug Administration [FDA] approved); and

2. Any limitations on the information presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion.

Disclaimer

This activity is intended for educational purposes only and does not establish a standard of care or replace clinical judgment. Any therapeutic or diagnostic strategies discussed must be evaluated in the context of each patient’s clinical circumstances, risks, and current evidence.

Learners should consult authoritative clinical guidelines and approved product information when considering treatment decisions.

All materials are used with permission. The views expressed are those of the faculty and do not necessarily reflect those of the accredited providers, MedAll, or any supporters.

Content is accurate as of the date of release.